Review: Advances in the Pathogenesis and Treatment of Immune Thrombocytopenia Associated with Viral Hepatitis.

immune thrombocytopenia pathogenesis treatment viral hepatitis

Journal

Global medical genetics
ISSN: 2699-9404
Titre abrégé: Glob Med Genet
Pays: Germany
ID NLM: 101769583

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 28 8 2023
pubmed: 28 8 2023
entrez: 28 8 2023
Statut: epublish

Résumé

Hepatitis B virus and hepatitis C virus are the hepatitis subtypes that most commonly induce immune thrombocytopenia (ITP). Although the pathogenesis of viral hepatitis-associated ITP remains unclear, it may involve antibody cross-reactivity due to molecular mimicry, the formation of virus-platelet immune complexes, and T cell-mediated suppression of bone marrow hematopoiesis. Moreover, there is significant correlation between platelet count and the severity of viral hepatitis, the risk of progression to liver cirrhosis, and clinical prognosis. However, treatment of viral hepatitis-associated ITP is hindered by some antiviral drugs. In this review, we summarize research progress to date on the pathogenesis and treatment of viral hepatitis-related ITP, hoping to provide a reference for clinical diagnosis and treatment.

Identifiants

pubmed: 37635907
doi: 10.1055/s-0043-1772771
pii: GMG-D-23-00046
pmc: PMC10449570
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

229-233

Informations de copyright

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).

Déclaration de conflit d'intérêts

Conflict of Interest None declared.

Références

Eur J Haematol. 2005 Nov;75(5):417-23
pubmed: 16191092
Gut. 2018 Oct;67(10):1903-1904
pubmed: 29101263
Blood. 2009 Apr 23;113(17):4086-93
pubmed: 19023115
N Engl J Med. 2007 Nov 29;357(22):2227-36
pubmed: 18046027
Platelets. 2015;26(7):672-9
pubmed: 25397356
J Gastroenterol Hepatol. 2003 Jun;18(6):638-44
pubmed: 12753144
J Gastroenterol Hepatol. 2012 Feb;27(2):286-90
pubmed: 21793908
Bull World Health Organ. 2019 Mar 1;97(3):230-238
pubmed: 30992636
Br J Haematol. 2005 Jun;129(6):818-24
pubmed: 15953010
J Gen Virol. 2006 Aug;87(Pt 8):2243-2251
pubmed: 16847120
J Biol Chem. 2008 Feb 8;283(6):3224-3230
pubmed: 18056258
Am J Gastroenterol. 1995 Jul;90(7):1146-7
pubmed: 7611214
Ann Hematol. 2004 Jul;83(7):434-40
pubmed: 14963696
Gastroenterology. 2014 Feb;146(2):442-52.e1
pubmed: 24126097
J Hepatol. 1996 Feb;24(2):135-40
pubmed: 8907565
Clin Liver Dis (Hoboken). 2019 Dec 20;14(5):183-186
pubmed: 31879561
Blood. 1998 Jul 15;92(2):520-8
pubmed: 9657752
Arch Intern Med. 2009 Feb 23;169(4):357-63
pubmed: 19237719
J Hepatol. 2013 Oct;59(4):738-45
pubmed: 23747755
J Clin Invest. 1986 Aug;78(2):411-7
pubmed: 3090103
J Hepatol. 2005 Jun;42(6):813-9
pubmed: 15885351
J Viral Hepat. 2022 May;29(5):306-316
pubmed: 35152507
Transplantation. 2005 Jun 15;79(11):1634-5
pubmed: 15940057
Nat Rev Clin Oncol. 2012 Jan 24;9(3):156-66
pubmed: 22271089
J Biol Chem. 2003 May 30;278(22):20358-66
pubmed: 12609975
Gut Liver. 2017 Nov 15;11(6):870-877
pubmed: 28750484
Eur J Gastroenterol Hepatol. 2016 Apr;28(4):398-404
pubmed: 26695428
Am J Gastroenterol. 2002 Aug;97(8):2040-5
pubmed: 12190174
J Gastroenterol. 2010 Aug;45(8):876-84
pubmed: 20339877
Gastroenterology. 2018 Sep;155(3):705-718
pubmed: 29778606
Biomed J. 2022 Oct;45(5):788-797
pubmed: 34508913
Liver Int. 2012 Feb;32 Suppl 1:2-8
pubmed: 22212565
Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):553-62
pubmed: 23817321
Blood. 2008 Feb 1;111(3):1234-9
pubmed: 17959856
Eur J Haematol. 2003 Mar;70(3):196-7
pubmed: 12605667
J Hepatol. 2009 Mar;50(3):631-3
pubmed: 19157626
N Engl J Med. 1999 Dec 30;341(27):2068-74
pubmed: 10615080

Auteurs

Yanmei Xu (Y)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, People's Republic of China.
Tianjin Institutes of Health Science, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, People's Republic of China.

Yunfei Chen (Y)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, People's Republic of China.
Tianjin Institutes of Health Science, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, People's Republic of China.

Lei Zhang (L)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, People's Republic of China.
Tianjin Institutes of Health Science, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, People's Republic of China.

Classifications MeSH